Heath Lab

James R. Heath lab at ISB and UW. Systems Biology, Immunology, Oncology, Physical Chemistry, Nanotechnology, Bioengineering.

[Heath Lab @LabHeath]

Check out the new @CellCellPress cover featuring our study on early risk factors of long COVID, led by @SuYapeng, Dan and Daniel, in collaboration with
Jason Goldman @Swedish, @HelenChuMD @uwmedicine, and many amazing scientists from @StanfordMed @fredhutch @UCSF @UCLA etc.

[ISB @isbsci]

Beautiful @CellCellPress cover! @allisonx @labheath @SuYapeng

[Helen Chu @HelenChuMD]

Incredible new Cell cover featuring the work to understand early predictors of long COVID, studies led by @isbsci @LabHeath Jason Goldman @Swedish, in collaboration with our #HAARVI research team @uwmedicine @McCullochMD @jenni_logue @SkiClimbSciNick

[Charlotte Schubert @schubertcm]

Researchers will recruit 900 patients for new clinical study on long-COVID, led by @LabHeath at @isbsci. Other investigators include @HelenChuMD
@UWMedicine and Dr. Jason Goldman at @Swedish
https://t.co/9wEyDqgRbj via @GeekWire

[ISB @isbsci]

As part of a nationwide effort to understand #LongCovid, @isbsci is leading a multi-site Pacific Northwest consortium as part of the @NIH-funded RECOVER initiative. @Swedish @providence @UWMedicine @LabHeath https://t.co/fC1eyEkNYT

[ISB @isbsci]

Our recent research on #LongCovid continues to make headlines. Check out this article from Emily Sohn, @NatGeo https://t.co/2nvfDHHr9y @SuYapeng, @LabHeath, @fredhutch, Jason Goldman

[ISB @isbsci]

The #LongCovid research by @labheath, @SuYapeng and many others was covered in this piece by @rddysum of @WSJ. @swedish @providence @fredhutch @CellCellPress

[Charlotte Schubert @schubertcm]

What predicts long-COVID? Study led by Seattle researchers at @isbsci provides some answers. Thank you to @LabHeath for the interview. https://t.co/AyKgIQcqbc via @GeekWire

[Cell @CellCellPress]

Now online! Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae https://t.co/dzZv0Qs7zc

[Waggoner Lab @LabWaggoner]

Longitudinal multiomics associate long-COVID sequalae with viremia, presence of autoAbs, and comorbities (T2D). Reactivation of latent viruses (#EBV) during CoV-2 and post-infection expansion of CTL implicated. @SuYapeng & Yuan & Chen Goldman/Heath labs
https://t.co/Gik5317q7Y

[Yapeng Su @SuYapeng]

Check out our #LongCOVID @CellCellPress paper @isbsci covered @NYTimes by @PamBelluck with insightful discussion from Drs. Steven Deeks, Avindra Nath, and @VirusesImmunity.

[Yapeng Su @SuYapeng]

Excited to share our #LongCovid #COVID-19 paper @CellCellPress. https://t.co/wFQsTPFEuK

[Helen Chu @HelenChuMD]

An important early look at factors associated with development of long COVID. Thanks #HAARVI participants for your role. It was a pleasure to collaborate with @labheath, Jason Goldman, and @isbsci on this work.

[Eric Topol @EricTopol]

New @CellCellPress
An in-depth assessment of over 200 people identifies factors that may predict #LongCovid, including #SARSCoV2 level in the blood, reactivation of EB virus, autoantibodies, and #T2DM.
https://t.co/jQD5FSUUK0 @labheath @isbsci @SuYapeng

[ISB @isbsci]

New research by @isbsci @labheath @suyapeng @swedish on #LongCovid covered in the New York Times. ⬇️🦠

[NYT Science @NYTScience]

Can scientists predict a person’s risk for developing long Covid? A new study found four biological factors that could be identified early and that correlated with whether people had lingering symptoms two or three months later. https://t.co/caoCJ0Zv9s

[Science in Seattle @science_seattle]

Dr. Jim Heath's (@LabHeath) team at @isbsci has identified several factors that can predict if a patient is likely to develop #LongCOVID. 🩺

Read about the implications of their findings here: 📌 https://t.co/zuYm0gZAR3

[ISB @isbsci]

An @isbsci -led study published by @CellCellPress has identified several factors that can predict if a patient is likely to develop #LongCOVID. See our story and video describing this work ⬇️ @SuYapeng @LabHeath @swedish @providence https://t.co/LicyWhLmH4

[Heath Lab @LabHeath]

Our longitudinal systematic investigation of 309 patients is out @cellcellpress. #LongCovid is anticipated by many factors early at diagnosis. Tour de force led by @SuYapeng, Daniel and Dan in collaboration with @swedish @providence @fredhutch @UWMedicine @Stanford @UCSF @UCLA

[ISB @isbsci]

Published online by @CellCellPress: @SuYapeng, Daniel Chen, Dan Yuan, @LabHeath & collaborators found factors that can predict if a patient is likely to develop #LongCovid. Congratulations! @swedish @providence @fredhutch @UWMedicine @Stanford @UCLA @UCSF https://t.co/eTDFDSZ5FC

[Fred Hutch Cancer Center @fredhutch]

In new work published Sept. 6 in @NatureBiotech, researchers from Fred Hutch and @isbsci dove deep into the metabolic changes in patients suffering from #COVID19. @jihoonwlee @SuYapeng @UW @MCBSeattle @LabHeath @Swedish https://t.co/ynb1pH0u0X

[ISB @isbsci]

@suyapeng, Dan Yuan, Daniel Chen & @labheath contributed to this paper published in @ImmunityCP https://t.co/bFGZxduad8